Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Alfonso-Triguero

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nanomaterials (Basel, Switzerland)|May 27, 2023
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?Paula Alfonso-Triguero, Julia Lorenzo, Ana Paula Candiota, et al.
Biomimetics (Basel, Switzerland)|September 27, 2024
Mussel-Inspired Multifunctional Polyethylene Glycol Nanoparticle InterfacesCarolina Casagualda, Alba López-Moral, Paula Alfonso-Triguero, et al.
Cancers|October 14, 2022
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?Daniel Ruiz-Molina, Xiaoman Mao, Paula Alfonso-Triguero, et al.
International Journal of Molecular Sciences|November 9, 2024
Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in GlioblastomaRafael Jiménez, Andrada Constantinescu, Muhube Yazir, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nanomaterials (Basel, Switzerland)|May 27, 2023
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?Paula Alfonso-Triguero, Julia Lorenzo, Ana Paula Candiota, et al.
Biomimetics (Basel, Switzerland)|September 27, 2024
Mussel-Inspired Multifunctional Polyethylene Glycol Nanoparticle InterfacesCarolina Casagualda, Alba López-Moral, Paula Alfonso-Triguero, et al.
Cancers|October 14, 2022
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?Daniel Ruiz-Molina, Xiaoman Mao, Paula Alfonso-Triguero, et al.
International Journal of Molecular Sciences|November 9, 2024
Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in GlioblastomaRafael Jiménez, Andrada Constantinescu, Muhube Yazir, et al.
Pageof 1